Complete Response of a Stage IV Mucinous Cystadenocarcinoma of the Ovary to Systemic Chemotherapy Employing Paclitaxel and Carboplatin

Publisher： Karger

E-ISSN： 1423-002x|52|3|210-214

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.52, Iss.3, 2001-10, pp. : 210-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survival Impact of Adjuvant Paclitaxel and Carboplatin for Early-Stage Ovarian Clear-Cell Carcinoma with Complete Surgical Staging

By  

Gynecologic and Obstetric Investigation, Vol. 72, Iss. 4, 2011-10 ,pp. : 252-256

Karger

Access to resources Recommend Favorite

Pilot Phase 2 Trial of 4 Months of Maintenance Pegylated Liposomal Doxorubicin in Patients with Advanced Ovarian Cancer after Complete Response to Platinum and Paclitaxel-Based Chemotherapy

By  

Gynecologic and Obstetric Investigation, Vol. 63, Iss. 1, 2006-06 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Primary Retroperitoneal Mucinous Cystadenocarcinoma: A Case Report and Review of the Literature

By  

Gynecologic and Obstetric Investigation, Vol. 70, Iss. 3, 2010-06 ,pp. : 186-191

Karger

Access to resources Recommend Favorite

Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary

By  

Gynecologic and Obstetric Investigation, Vol. 81, Iss. 5, 2015-11 ,pp. : 411-415

Karger

Access to resources Recommend Favorite

Metastatic Mucinous Adenocarcinoma of the Ovary Is Characterized by Advanced Patient Age, Small Tumor Size, and Elevated Serum CA125

By  

Gynecologic and Obstetric Investigation, Vol. 72, Iss. 3, 2011-09 ,pp. : 196-202

Karger

Access to resources Recommend Favorite